Stereotaxis (STXS) Change in Account Payables (2010 - 2026)
Stereotaxis (STXS) posted quarterly Change in Account Payables of -$49000.0 for Q1 2026, down 105.75% year-over-year from $852000.0 in Q1 2025, and down 136.3% quarter-over-quarter from $135000.0 in Q4 2025.
Stereotaxis (STXS) Change in Account Payables (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Change in Account Payables for 17 consecutive years, with -$49000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 105.75% year-over-year to -$49000.0; the TTM figure through Mar 2026 stood at -$1.8 million (down 219.29% YoY), while the FY2025 annual figure was -$880000.0, down 216.09% from the prior year.
- Change in Account Payables fell to -$49000.0 in Q1 2026 per STXS's latest filing, from $135000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.9 million in Q2 2022 and bottomed at -$2.1 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$7176.5 across 5 years, with a median of $117000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables tumbled 1375.86% — and 2025, when it jumped 628.21%.
- Stereotaxis' Change in Account Payables stood at -$856000.0 in 2022, then surged by 93.93% to -$52000.0 in 2023, then slumped by 1226.92% to -$690000.0 in 2024, then soared by 119.57% to $135000.0 in 2025, then sank by 136.3% to -$49000.0 in 2026.
- Business Quant data shows STXS's Change in Account Payables at -$49000.0 in Q1 2026, $135000.0 in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49,000.00 |
| Mar 31, 2026 | -49,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | -2.08 Mn |
| Sep 30, 2025 | -2.08 Mn |
| Jun 30, 2025 | 210,000.00 |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | -690,000.00 |
| Dec 31, 2024 | -690,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | 829,000.00 |
| Jun 30, 2024 | 829,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | -52,000.00 |
| Dec 31, 2023 | -52,000.00 |